ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 898 filers reported holding ISHARES TR in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $921 | -39.8% | 6,709 | -39.9% | 0.08% | -40.6% |
Q1 2024 | $1,531 | +4.4% | 11,159 | +3.3% | 0.14% | -10.4% |
Q4 2023 | $1,467 | +9.8% | 10,800 | -1.1% | 0.15% | 0.0% |
Q3 2023 | $1,336 | -11.4% | 10,925 | -8.0% | 0.15% | -7.2% |
Q2 2023 | $1,508 | -2.5% | 11,875 | -0.8% | 0.17% | -13.5% |
Q1 2023 | $1,547 | -1.9% | 11,975 | -0.3% | 0.19% | -9.9% |
Q4 2022 | $1,577 | -99.9% | 12,010 | -16.1% | 0.21% | -12.7% |
Q3 2022 | $1,674,000 | -3.1% | 14,310 | -2.6% | 0.24% | +7.0% |
Q2 2022 | $1,727,000 | -16.6% | 14,685 | -7.6% | 0.23% | +5.6% |
Q1 2022 | $2,070,000 | -12.4% | 15,890 | +2.6% | 0.22% | -8.5% |
Q4 2021 | $2,364,000 | -2.6% | 15,490 | +3.2% | 0.24% | -13.6% |
Q3 2021 | $2,428,000 | -0.5% | 15,015 | +0.7% | 0.27% | +3.0% |
Q2 2021 | $2,439,000 | +9.6% | 14,905 | +0.8% | 0.26% | +5.2% |
Q1 2021 | $2,225,000 | +0.5% | 14,780 | +1.2% | 0.25% | -10.3% |
Q4 2020 | $2,213,000 | +28.9% | 14,605 | +15.2% | 0.28% | +15.6% |
Q3 2020 | $1,717,000 | – | 12,680 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |